Search

01/10/2024 Contextual-compassion training for borderline personality disorder with long lasting symptoms: A randomized clinical trial
Casellas-Pujol, E, Soler, J, Schmidt, C, Soria-Madrid, A, Elices, M, Pascual, JC. Contextual-compassion training for borderline personality disorder with long lasting symptoms: A randomized clinical trial. Journal of Contextual Behavioral Science. 2024; 34DOI:10.1016/j.jcbs.2024.100846. PMID:. IF:3.000(Q1/3D).
01/10/2024 A pilot, randomized, three-arm, dose-finding, placebo-controlled, parallel study to evaluate the use of nabiximols (THC plus CBD, Sativex®) for cannabis detoxification treatment versus treatment as usual
Bonifacio, DM, Rodríguez, MP, Perelló, PM, Hurtado, JC, Albet, JT, Tutusaus, XR, Arbós, RMA. A pilot, randomized, three-arm, dose-finding, placebo-controlled, parallel study to evaluate the use of nabiximols (THC plus CBD, Sativex®) for cannabis detoxification treatment versus treatment as usual. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
02/09/2024 How does mindfulness skills training work to improve emotion dysregulation in borderline personality disorder?
Schmidt, C, Soler, J, Vega, D, Nicolaou, S, Arias, L, Pascual, JC. How does mindfulness skills training work to improve emotion dysregulation in borderline personality disorder?. Borderline Personality Disorder and Emotion Dysregulation. 2024; 11(1)DOI:10.1186/s40479-024-00265-0. PMID:39218933. IF:2.700(Q2/4D).
01/09/2024 Cognitive insight in first-episode psychosis: Exploring the complex relationship between executive functions and social cognition
López-Carrilero, R, Lo Monaco, M, Frígola-Capell, E, Ferrer-Quintero, M, Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Vila-Badia, R, Punsoda-Puche, P, Birulés, I, Peláez, T, Pousa, E, Grasa, E, Barajas, A, Ruiz-Delgado, I, Barrigón, ML, Gonzalez-Higueras, F, Lorente-Rovira, E, Gutiérrez-Zotes, A, Cid, J, Legido, T, Ayesa-Arriola, R, Moritz, S, Ochoa, S. Cognitive insight in first-episode psychosis: Exploring the complex relationship between executive functions and social cognition. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2024; 17(3)DOI:10.1016/j.sjpmh.2024.01.002. PMID:38219901. IF:2.800(Q2/4D).
01/09/2024 Is it possible to predict hospitalisation during intensive home treatment? A retrospective cohort study
Martín-Blanco, A, González-Fernández, A, Vieira, S, Farré, A, Isern, C, Avila-Parcet, A, Gausachs, E, Patrizi, B, Cardoner, N, Portella, MJ. Is it possible to predict hospitalisation during intensive home treatment? A retrospective cohort study. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2024; 28(3-4)DOI:10.1080/13651501.2025.2461798. PMID:39954709. IF:2.700(Q2/4D).
01/08/2024 Outcomes of Bariatric Surgery in Patients with Schizophrenia
Miñambres, I, Rubio-Herrera, MA, Nicolau, J, Milad, C, Morales, MJ, Bueno, M, Calañas, A, Carceller-Sindreu, M, de Hollanda, A. Outcomes of Bariatric Surgery in Patients with Schizophrenia. Nutrients. 2024; 16(15)DOI:10.3390/nu16152487. PMID:39125367. IF:5.000(Q1/2D).
01/08/2024 Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group
Hilbert, K, Boeken, OJ, Langhammer, T, Groenewold, NA, Bas-Hoogendam, JM, Aghajani, M, Zugman, A, Åhs, F, Arolt, V, Beesdo-Baum, K, Björkstrand, J, Blackford, JU, Blanco-Hinojo, L, Böhnlein, J, Bülow, R, Cano, M, Cardoner, N, Caseras, X, Dannlowski, U, Domschke, K, Fehm, L, Feola, B, Fredrikson, M, Goossens, L, Grabe, HJ, Grotegerd, D, Gur, RE, Hamm, AO, Harrewijn, A, Heinig, I, Herrmann, MJ, Hofmann, D, Jackowski, AP, Jansen, A, Kaczkurkin, AN, Kindt, M, Kingsley, EN, Kircher, T, Klahn, AL, Koelkebeck, K, Krug, A, Kugel, H, Larsen, B, Leehr, EJ, Leonhardt, L, Lotze, M, Margraf, J, Michalowski, J, Muehlhan, M, Nenadic, I, Pan, PM, Pauli, P, Peñate, W, Pittig, A, Plag, J, Pujol, J, Richter, J, Rivero, FL, Salum, GA, Satterthwaite, TD, Schäfer, A, Schäfer, J, Schienle, A, Schneider, S, Schrammen, E, Schruers, K, Schulz, SM, Seidl, E, Stark, RM, Stein, F, Straube, B, Straube, T, Ströhle, A, Suchan, B, Thomopoulos, SI, Ventura-Bort, C, Visser, R, Völzke, H, Wabnegger, A, Wannemüller, A, Wendt, J, Wiemer, J, Wittchen, HU, Wittfeld, K, Wright, B, Yang, Y, Zilverstand, A, Zwanzger, P, Veltman, DJ, Winkler, AM, Pine, DS, Jahanshad, N, Thompson, PM, Stein, DJ, Van der Wee, NJ, Lueken, U. Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group. AMERICAN JOURNAL OF PSYCHIATRY. 2024; 181(8)DOI:10.1176/appi.ajp.20230032. PMID:38859702. IF:14.700(Q1/1D).
01/05/2024 Non-fatal suicide behaviours across phases in the COVID-19 pandemic: a population-based study in a Catalan cohort
Serrano-Gimeno, V, Diestre, A, Agustin-Alcain, M, Portella, MJ, de Diego-Adelino, J, Tiana, T, Cheddi, N, Distefano, A, Dominguez, G, Arias, M, Cardoner, V, Puigdemont, D, Perez, V, Cardoner, N. Non-fatal suicide behaviours across phases in the COVID-19 pandemic: a population-based study in a Catalan cohort. LANCET PSYCHIATRY. 2024; 11(5)DOI:10.1016/S2215-0366(24)00065-8. PMID:38631785. IF:24.800(Q1/1D).
01/04/2024 Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression
Young, AH, Baune, BT, Cardoner, N, Frey, R, Ito, T, Kambarov, Y, Lacerda, A, Rive, B, von Holt, C, Oliveira-Maia, AJ. Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression. EUROPEAN PSYCHIATRY. 2024; 67DOI:10.1192/j.eurpsy.2024.749. PMID:. IF:6.700(Q1/1D).
01/04/2022 Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat
Querol-Vilaseca, M, Sirisi, S, Molina-Porcel, L, Molina, B, Pegueroles, J, Ferrer-Raventos, P, Nunez-Llaves, R, Dols-Icardo, O, Balasa, M, Iulita, MF, Blesa, R, Belbin, O, Clarimon, J, Fortea, J, Gelpi, E, Sanchez-Valle, R, Lleo, A. Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2022; 48(3)DOI:10.1111/nan.12781. PMID:34825396. IF:5.000(Q1/2D).
01/03/2022 Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
Hostettler, IC, Wilson, D, Fiebelkorn, CA, Aum, D, Ameriso, SF, Eberbach, F, Beitzke, M, Kleinig, T, Phan, T, Marchina, S, Schneckenburger, R, Carmona-Iragui, M, Charidimou, A, Mourand, I, Parreira, S, Ambler, G, Jager, HR, Singhal, S, Ly, J, Ma, H, Touze, E, Geraldes, R, Fonseca, AC, Melo, T, Labauge, P, Lefevre, PH, Viswanathan, A, Greenberg, SM, Fortea, J, Apoil, M, Boulanger, M, Viader, F, Kumar, S, Srikanth, V, Khurram, A, Fazekas, F, Bruno, V, Zipfel, GJ, Refai, D, Rabinstein, A, Graff-Radford, J, Werring, DJ. Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis. JOURNAL OF NEUROLOGY. 2022; 269(3)DOI:10.1007/s00415-021-10706-3. PMID:34272978. IF:6.000(Q1/2D).
27/01/2022 Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Gobom, J, Parnetti, L, Rosa-Neto, P, Vyhnalek, M, Gauthier, S, Cataldi, S, Lerch, O, Laczo, J, Cechova, K, Clarin, M, Benet, AI, Pascoal, TA, Rahmouni, N, Vandijck, M, Huyck, E, Le Bastard, N, Stevenson, J, Chamoun, M, Alcolea, D, Lleo, A, Andreasson, U, Verbeek, MM, Bellomo, G, Rinaldi, R, Ashton, N, Zetterberg, H, Sheardova, K, Hort, J, Blennow, K. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(2)DOI:10.1515/cclm-2021-0651. PMID:34773730. IF:6.800(Q1/2D).
01/01/2022 Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum
Baque, L, Machuca, MJ, Santos-Santos, MA. Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum. REVISTA DE NEUROLOGIA. 2022; 74(2)DOI:10.33588/rn.7402.2021197. PMID:35014018. IF:1.200(Q4/10D).
10/12/2021 Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
Zhu, N, Santos-Santos, M, Illan-Gala, I, Montal, V, Estelles, T, Barroeta, I, Altuna, M, Arranz, J, Munoz, L, Belbin, O, Sala, I, Sanchez-Saudinos, MB, Subirana, A, Videla, L, Pegueroles, J, Blesa, R, Clarimon, J, Carmona-Iragui, M, Fortea, J, Lleo, A, Alcolea, D. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Translational Neurodegeneration. 2021; 10(1)DOI:10.1186/s40035-021-00275-w. PMID:34893073. IF:9.883(Q1/1D).
01/12/2021 Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults
Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Lois, C, Hanseeuw, B, Vilaplana, E, Schultz, AP, Properzi, MJ, Scott, MR, Amariglio, R, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. MOLECULAR PSYCHIATRY. 2021; 26(12)DOI:10.1038/s41380-021-01290-z. PMID:34588623. IF:13.437(Q1/1D).
01/12/2021 Specific Susceptibility to COVID-19 in Adults with Down Syndrome (Mar, 10.1007/s12017-021-08651-5, 2021)
Illouz, T, Biragyn, A, Frenkel-Morgenstern, M, Weissberg, O, Gorohovski, A, Merzon, E, Green, I, Iulita, F, Flores-Aguilar, L, Dierssen, M, De Toma, I, Lifshitz, H, Antonarakis, SE, Yu, EE, Herault, Y, Potier, MC, Botte, A, Roper, R, Sredni, B, Sarid, R, London, J, Mobley, W, Strydom, A, Okun, E. Specific Susceptibility to COVID-19 in Adults with Down Syndrome (Mar, 10.1007/s12017-021-08651-5, 2021). NEUROMOLECULAR MEDICINE. 2021; 23(4)DOI:10.1007/s12017-021-08657-z. PMID:33948879. IF:4.103(Q2/5D).
01/12/2021 Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy
Gelpi, E, Aldecoa, I, Lopez-Villegas, D, Abellan-Vidal, MT, Mercadel-Fananas, P, Fortea, J, Ribosa, R, Morenas, E, Gomez-Anson, B, Molina-Porcel, L, Ximelis, T, Borrego, S, Antonell, A, Rovelet-Lecrux, A, Klotz, S, Andres-Benito, P, Sanchez-Valle, R, Ferrer, I. Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2021; 47(7)DOI:10.1111/nan.12707. PMID:33730418. IF:6.250(Q1/2D).
01/12/2021 Specific Susceptibility to COVID-19 in Adults with Down Syndrome
Illouz, T, Biragyn, A, Frenkel-Morgenstern, M, Weissberg, O, Gorohovski, A, Merzon, E, Green, I, Iulita, F, Flores-Aguilar, L, Sotos, MDD, De Toma, I, Lifshitz, H, Antonarakis, SE, Yu, E, Herault, Y, Potier, MC, Botte, A, Roper, R, Sredni, B, Sarid, R, London, J, Mobley, W, Strydom, A, Okun, E. Specific Susceptibility to COVID-19 in Adults with Down Syndrome. NEUROMOLECULAR MEDICINE. 2021; 23(4)DOI:10.1007/s12017-021-08651-5. PMID:33660221. IF:4.103(Q2/5D).
16/11/2021 Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy (vol 13, 160, 2021)
De Kort, AM, Kuiperij, HB, Alcolea, D, Kersten, I, Versleijen, AAM, Greenberg, SM, Stoops, E, Schreuder, FHBM, Klijn, CJM, Lleo, A, Claassen, JAHR, Verbeek, MM. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy (vol 13, 160, 2021). Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00929-x. PMID:34784952. IF:8.831(Q1/1D).
01/11/2021 Alternative platelet activation pathways and their role in neurodegenerative diseases
Ferrer-Raventos, P, Beyer, K. Alternative platelet activation pathways and their role in neurodegenerative diseases. NEUROBIOLOGY OF DISEASE. 2021; 159DOI:10.1016/j.nbd.2021.105512. PMID:34537329. IF:7.046(Q1/2D).
01/11/2021 Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Alcolea, D, Delaby, C, Munoz, L, Torres, S, Estelles, T, Zhu, N, Barroeta, I, Carmona-Iragui, M, Illan-Gala, I, Santos-Santos, MA, Altuna, M, Sala, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Subirana, A, Pegueroles, J, Hirtz, C, Vialaret, J, Lehmann, S, Karikari, TK, Ashton, NJ, Blennow, K, Zetterberg, H, Belbin, O, Blesa, R, Clarimon, J, Fortea, J, Lleo, A. Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2021; 92(11)DOI:10.1136/jnnp-2021-326603. PMID:34103344. IF:13.654(Q1/1D).
01/11/2021 Cytokines as new biomarkers of skin wound vitality
Peyron, PA, Colomb, S, Becas, D, Adriansen, A, Gauchotte, G, Tiers, L, Marin, G, Lehmann, S, Baccino, E, Delaby, C, Hirtz, C. Cytokines as new biomarkers of skin wound vitality. INTERNATIONAL JOURNAL OF LEGAL MEDICINE. 2021; 135(6)DOI:10.1007/s00414-021-02659-z. PMID:34313846. IF:2.791(Q1/3D).
01/11/2021 Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J, Zaman, SH, Hartley, S, Rafii, MS, Head, E, Carmona-Iragui, M. Alzheimer's disease associated with Down syndrome: a genetic form of dementia. LANCET NEUROLOGY. 2021; 20(11)DOI:10.1016/S1474-4422(21)00245-3. PMID:34687637. IF:59.935(Q1/1D).
01/11/2021 Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Xu, J, Green, R, Kim, M, Lord, J, Ebshiana, A, Westwood, S, Baird, AL, Nevado-Holgado, AJ, Shi, L, Hye, A, Snowden, SG, Bos, I, Vos, SJB, Vandenberghe, R, Teunissen, CE, Kate, MT, Scheltens, P, Gabel, S, Meersmans, K, Blin, O, Richardson, J, De Roeck, EE, Engelborghs, S, Sleegers, K, Bordet, R, Rami, L, Kettunen, P, Tsolaki, M, Verhey, FRJ, Alcolea, D, Lleo, A, Peyratout, G, Tainta, M, Johannsen, P, Freund-Levi, Y, Froelich, L, Dobricic, V, Frisoni, GB, Molinuevo, JL, Wallin, A, Popp, J, Martinez-Lage, P, Bertram, L, Blennow, K, Zetterberg, H, Streffer, J, Visser, PJ, Lovestone, S, Proitsi, P, Legido-Quigley, C. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines. 2021; 9(11)DOI:10.3390/biomedicines9111610. PMID:34829839. IF:4.757(Q2/4D).
18/10/2021 Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease
Ximelis, T, Marin-Moreno, A, Espinosa, JC, Erana, H, Charco, JM, Hernandez, I, Riveira, C, Alcolea, D, Gonzalez-Roca, E, Aldecoa, I, Molina-Porcel, L, Parchi, P, Rossi, M, Castilla, J, Ruiz-Garcia, R, Gelpi, E, Torres, JM, Sanchez-Valle, R. Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00912-6. PMID:34663460. IF:8.831(Q1/1D).
04/10/2021 Divergent connectomic organization delineates genetic evolutionary traits in the human brain
Bueicheku, E, Gonzalez-de-Echavarri, JM, Ortiz-Teran, L, Montal, V, Uquillas, FD, De Marcos, L, Orwig, W, Kim, CM, Ortiz-Teran, E, Basaia, S, Diez, I, Sepulcre, J. Divergent connectomic organization delineates genetic evolutionary traits in the human brain. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-99082-6. PMID:34608211. IF:4.997(Q2/3D).
26/09/2021 Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease
Barranco, N, Pla, V, Alcolea, D, Sanchez-Dominguez, I, Fischer-Colbrie, R, Ferrer, I, Lleo, A, Aguado, F. Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease. Translational Neurodegeneration. 2021; 10(1)DOI:10.1186/s40035-021-00263-0. PMID:34565482. IF:9.883(Q1/1D).
24/09/2021 Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
De Kort, AM, Kuiperij, HB, Alcolea, D, Kersten, I, Versleijen, AAM, Greenberg, SM, Stoops, E, Schreuder, FHBM, Klijn, CJM, Lleo, A, Claassen, JAHR, Verbeek, MM. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00899-0. PMID:34560885. IF:8.831(Q1/1D).
01/09/2021 CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms, BM, Gobom, J, Teunissen, C, Dobricic, V, Tsolaki, M, Verhey, F, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Bertram, L, Lovestone, S, Streffer, J, Vos, S, Blennow, K, Scheltens, P, Zetterberg, H, Visser, PJ, ADNI. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021; 9(3)DOI:10.3390/proteomes9030036. PMID:34449748. IF:(Q/D).
01/09/2021 Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
Ledreux, A, Thomas, S, Hamlett, ED, Trautman, C, Gilmore, A, Hager, ER, Paredes, DA, Margittai, M, Fortea, J, Granholm, AC. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10173931. PMID:34501378. IF:4.964(Q2/4D).
01/09/2021 Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes
Horta-Barba, A, Pagonabarraga, J, Martinez-Horta, S, Busteed, L, Pascual-Sedano, B, Illan-Gala, I, Marin-Lahoz, J, Aracil-Bolanos, I, Perez-Perez, J, Sampedro, F, Bejr-Kasem, H, Kulisevsky, J. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. JOURNAL OF NEUROLOGY. 2021; 268(9)DOI:10.1007/s00415-021-10511-y. PMID:33704556. IF:6.682(Q1/2D).
01/09/2021 Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Montal, V, Barroeta, I, Bejanin, A, Pegueroles, J, Carmona-Iragui, M, Altuna, M, Benejam, B, Videla, L, Fernandez, S, Padilla, C, Aranha, MR, Iulita, MF, Vidal-Pineiro, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. ANNALS OF NEUROLOGY. 2021; 90(3)DOI:10.1002/ana.26178. PMID:34309066. IF:11.274(Q1/1D).
19/08/2021 Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, E, Martinez-Heras, E, Montal, V, Vilaplana, E, Lopez-Soley, E, Radua, J, Sola-Valls, N, Montejo, C, Blanco, Y, Pulido-Valdeolivas, I, Sepulveda, M, Andorra, M, Berenguer, J, Villoslada, P, Martinez-Lapiscina, EH, Prados, F, Saiz, A, Fortea, J, Llufriu, S. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-96132-x. PMID:34413373. IF:4.997(Q2/3D).
01/08/2021 Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
de Asua, DR, Mayer, MA, Ortega, MD, Borrel, JM, Bermejo, TD, Gonzalez-Lamuno, D, Manso, C, Moldenhauer, F, Carmona-Iragui, M, Huls, A, Sherman, SL, Strydom, A, de la Torre, R, Dierssen, M, Spanish Trisomy 21 Res Soc COVID-1. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163748. PMID:34442043. IF:4.964(Q2/4D).
01/08/2021 Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study
Carmona-Iragui, M, Alcolea, D, Barroeta, I, Videla, L, Munoz, L, Van Pelt, KL, Schmitt, FA, Lightner, DD, Koehl, LM, Jicha, G, Sacco, S, Mircher, C, Pape, SE, Hithersay, R, Clare, ICH, Holland, AJ, Nubling, G, Levin, J, Zaman, SH, Strydom, A, Rebillat, AS, Head, E, Blesa, R, Lleo, A, Fortea, J. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. LANCET NEUROLOGY. 2021; 20(8)DOI:10.1016/S1474-4422(21)00129-0. PMID:34302785. IF:59.935(Q1/1D).
21/07/2021 Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies
Shi, L, Buckley, NJJ, Bos, I, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ. Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies. Frontiers in Aging Neuroscience. 2021; 13DOI:10.3389/fnagi.2021.712545. PMID:34366831. IF:5.702(Q1/3D).
04/07/2021 Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition
Flores-Aguilar, L, Iulita, MF, Orciani, C, Tanna, N, Yang, JY, Bennett, DA, Cuello, AC. Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition. Journal of Neuroinflammation. 2021; 18(1)DOI:10.1186/s12974-021-02169-0. PMID:34218796. IF:9.589(Q1/1D).
01/07/2021 Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
Altuna, M, Gimenez, S, Fortea, J. Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity. Journal of Clinical Medicine. 2021; 10(13)DOI:10.3390/jcm10132776. PMID:34202784. IF:4.964(Q2/4D).
01/07/2021 Sleep Disorders in Adults with Down Syndrome
Gimenez, S, Altuna, M, Blessing, E, Osorio, RM, Fortea, J. Sleep Disorders in Adults with Down Syndrome. Journal of Clinical Medicine. 2021; 10(14)DOI:10.3390/jcm10143012. PMID:34300177. IF:4.964(Q2/4D).
01/07/2021 Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-beta positivity
Tort-Merino, A, Valech, N, Laine, M, Olives, J, Leon, M, Ecay-Torres, M, Estanga, A, Martinez-Lage, P, Fortea, J, Molinuevo, JL, Sanchez-Valle, R, Rodriguez-Fornells, A, Rami, L. Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-beta positivity. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2021; 36(7)DOI:10.1002/gps.5539. PMID:33792089. IF:3.850(Q2/3D).